See more : Golconda Gold Ltd. (GGGOF) Income Statement Analysis – Financial Results
Complete financial analysis of Careteq Limited (CTQ.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Careteq Limited, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- PT Wulandari Bangun Laksana Tbk (BSBK.JK) Income Statement Analysis – Financial Results
- Dürr Aktiengesellschaft (DURYY) Income Statement Analysis – Financial Results
- The Toronto-Dominion Bank (TD) Income Statement Analysis – Financial Results
- Trajectory Alpha Acquisition Corp. (TCOA) Income Statement Analysis – Financial Results
- Naga Dhunseri Group Limited (NDGL.NS) Income Statement Analysis – Financial Results
Careteq Limited (CTQ.AX)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.careteq.com.au
About Careteq Limited
Careteq Limited, a health-tech company, provides software as a service (SaaS)-based assistive living technology and services that focuses on meeting the needs in the health, aged, and home care sectors worldwide. The company develops and commercializes a suite of products that sit on its proprietary SaaS based assistive living technology platform for use by the elderly, disabled, and vulnerable individuals. It also offers medication management services, which include expert geriatric clinical pharmacy decision support services to general practitioners. The company was founded in 2016 and is based in Melbourne, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 7.23M | 5.52M | 4.43M | 735.44K | 146.46K |
| Cost of Revenue | 486.95K | 7.96M | 283.71K | 2.76M | 1.47M |
| Gross Profit | 6.74M | -2.44M | 4.14M | -2.03M | -1.33M |
| Gross Profit Ratio | 93.27% | -44.14% | 93.59% | -275.74% | -905.18% |
| Research & Development | -74.23K | 104.80K | 29.21K | 8.36K | 20.81K |
| General & Administrative | 7.26M | 7.66M | 6.70M | 420.55K | 618.57K |
| Selling & Marketing | 0.00 | -6.53M | 0.00 | 0.00 | 0.00 |
| SG&A | 7.26M | 1.13M | 6.70M | 420.55K | 618.57K |
| Other Expenses | 47.86K | 828.73K | -226.53K | -129.98K | 0.00 |
| Operating Expenses | 7.23M | 1.23M | 9.06M | 558.88K | 639.38K |
| Cost & Expenses | 7.23M | 9.19M | 9.34M | 3.32M | 2.11M |
| Interest Income | 0.00 | 15.10K | 112.34K | 3.00 | 847.00 |
| Interest Expense | 108.50K | 15.10K | 112.34K | 353.77K | 61.61K |
| Depreciation & Amortization | 486.95K | 436.00K | 33.03K | 38.72K | 37.47K |
| EBITDA | -826.62K | -3.57M | -5.90M | -5.06M | -1.93M |
| EBITDA Ratio | -11.43% | -58.54% | -115.27% | -346.47% | -1,316.15% |
| Operating Income | -1.93M | -3.67M | -5.14M | -2.59M | -1.97M |
| Operating Income Ratio | -26.68% | -66.43% | -116.02% | -351.74% | -1,341.74% |
| Total Other Income/Expenses | 507.59K | -15.10K | -1.15M | -2.86M | -385.22K |
| Income Before Tax | -1.42M | -4.69M | -5.25M | -5.45M | -2.35M |
| Income Before Tax Ratio | -19.67% | -84.95% | -118.55% | -741.30% | -1,604.76% |
| Income Tax Expense | 330.38K | -570.55K | -114.19K | -222.47K | -441.71K |
| Net Income | -2.67M | -4.33M | -5.25M | -5.23M | -1.91M |
| Net Income Ratio | -36.86% | -78.40% | -118.55% | -711.05% | -1,303.17% |
| EPS | -0.01 | -0.03 | -0.04 | -0.04 | -0.01 |
| EPS Diluted | -0.01 | -0.03 | -0.04 | -0.04 | -0.01 |
| Weighted Avg Shares Out | 216.22M | 141.54M | 141.54M | 141.54M | 141.54M |
| Weighted Avg Shares Out (Dil) | 216.22M | 141.54M | 141.54M | 141.54M | 141.54M |
Source: https://incomestatements.info
Category: Stock Reports